This Cure Is Personal: Test of Adrenal Cancer Drug Came Too Late for One of

This cure is personal: Test of adrenal cancer drug came too late for one of
The company announced last month that it had begun giving patients its oral drug treatment. "We hoped we could get her enrolled in trials, but we couldn't," said co-founder, President and CEO Julia Owens. Atterocor is a University of Michigan spinoff …
Read more on Crain’s Detroit Business

 

Doctors argue for decision aids to promote patient engagement
“The gut is a big part of this,” said Dr. Steven Katz, a professor of medicine, health management and policy at the University of Michigan who studies decisionmaking and communication in cancer care. “The gut rules a lot. It's the low part of our brain …
Read more on ModernHealthcare.com

 

Health care reform update – November 25, 2013
Citing the aggressive marketing in which the company has been engaged, the FDA expressed concern about the accuracy of the tests and how consumers will interpret test results and impact their decision-making on current and future treatments. … Chao …
Read more on Lexology (registration)